{"id":"ci-581-b","safety":{"commonSideEffects":[{"rate":null,"effect":"Dissociative effects / emergence reactions"},{"rate":null,"effect":"Increased blood pressure"},{"rate":null,"effect":"Increased heart rate"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CI-581-b blocks N-methyl-D-aspartate (NMDA) glutamate receptors, which interrupts pain signal transmission and produces dissociative anesthesia characterized by preserved airway reflexes and analgesia. This mechanism allows for procedural sedation and anesthesia while maintaining spontaneous respiration and protective airway responses.","oneSentence":"CI-581-b is a dissociative anesthetic that acts as an NMDA receptor antagonist to produce rapid-onset anesthesia and analgesia.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:05:50.082Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anesthesia induction and maintenance"},{"name":"Procedural sedation and analgesia"}]},"trialDetails":[{"nctId":"NCT05086250","phase":"EARLY_PHASE1","title":"Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2022-10-20","conditions":"Anxiety, Pancreatic Cancer","enrollment":20},{"nctId":"NCT06419439","phase":"PHASE2","title":"Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-12-03","conditions":"Chronic Low Back Pain, Depression","enrollment":44},{"nctId":"NCT06077487","phase":"PHASE4","title":"Ketamine-assisted Therapy for Advanced GI Cancer","status":"TERMINATED","sponsor":"Brian Anderson, MD","startDate":"2024-05-17","conditions":"Pancreatic Ductal Adenocarcinoma, Pain, Acute, Gastrointestinal Cancers","enrollment":1},{"nctId":"NCT05663801","phase":"PHASE2","title":"Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2022-12-01","conditions":"Cancer, Breast","enrollment":72},{"nctId":"NCT04177706","phase":"PHASE2","title":"Ketamine for the Treatment of Opioid Use Disorder and Depression","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-12-17","conditions":"Depression, Opioid-use Disorder, Opioid Abuse","enrollment":21},{"nctId":"NCT05591105","phase":"","title":"The Postoperative Lidocaine and Ketamine Effects on Morphine Requirement in Bariatric Surgery","status":"COMPLETED","sponsor":"Tiva Group","startDate":"2023-06-15","conditions":"Pharmacological Action, Post Operative Pain, Opioid Use","enrollment":64},{"nctId":"NCT05552391","phase":"PHASE4","title":"Dexametomedine Versus Ketamine as an Adjuvant in Erector Spinae Block for Perioperative Thoracotomy Pain Control","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2022-09-01","conditions":"Post Operative Pain","enrollment":90},{"nctId":"NCT03345173","phase":"PHASE3","title":"Facilitating Rapid Naltrexone Initiation","status":"ACTIVE_NOT_RECRUITING","sponsor":"New York State Psychiatric Institute","startDate":"2017-11-25","conditions":"Opioid Dependence","enrollment":100},{"nctId":"NCT06021717","phase":"PHASE4","title":"PCA Ketamine-Morphine VS PCA Morphine as Post-Operative Analgesia in Colorectal Surgery","status":"COMPLETED","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2018-04-05","conditions":"Ketamine, Morphine","enrollment":60},{"nctId":"NCT06010056","phase":"PHASE4","title":"PCA Ketamine-Morphine VS PCA Morphine as Post-Operative Analgesia in Colorectal Surgery.","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2018-04-05","conditions":"Ketamine, Morphine","enrollment":60},{"nctId":"NCT04938713","phase":"NA","title":"Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome.","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de Charleroi","startDate":"2021-07-01","conditions":"Fibromyalgia","enrollment":50},{"nctId":"NCT03421275","phase":"PHASE4","title":"Intranasal Esketamine and Fentanyl for Pain in Minor Trauma","status":"UNKNOWN","sponsor":"Anna Meuronen, MD","startDate":"2017-12-01","conditions":"Acute Pain Due to Trauma","enrollment":105},{"nctId":"NCT04259476","phase":"PHASE1","title":"Low Dose Perioperative Ketamine Infusion and it's Effect on Postoperative Pain Score, Sedation Score and Narcotic Consumption in Patients Undergoing Spine Surgery: A Prospective Randomized Double Blind Control Trial.","status":"UNKNOWN","sponsor":"Services Institute of Medical Sciences, Pakistan","startDate":"2020-01-01","conditions":"for Post-operative Pain Relief in Spine Surgeries","enrollment":60},{"nctId":"NCT03788889","phase":"PHASE4","title":"Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine","status":"WITHDRAWN","sponsor":"Santa Barbara Cottage Hospital","startDate":"2019-04-12","conditions":"Alcohol Withdrawal Syndrome","enrollment":""},{"nctId":"NCT01504659","phase":"PHASE2, PHASE3","title":"Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder","status":"TERMINATED","sponsor":"Juvenile Bipolar Research Foundation","startDate":"2012-07","conditions":"Bipolar Disorder","enrollment":5},{"nctId":"NCT01100255","phase":"PHASE2","title":"Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2010-04","conditions":"Obsessive-Compulsive Disorder","enrollment":15},{"nctId":"NCT02732132","phase":"PHASE4","title":"A Comparison of the Sedation During Endoscopy in Children","status":"COMPLETED","sponsor":"Kanuni Sultan Suleyman Training and Research Hospital","startDate":"2015-01","conditions":"Failed Moderate Sedation During Procedure","enrollment":238},{"nctId":"NCT01316744","phase":"PHASE3","title":"Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain","status":"UNKNOWN","sponsor":"University of Glasgow","startDate":"2009-04","conditions":"Cancer","enrollment":214},{"nctId":"NCT00520104","phase":"PHASE1","title":"Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine","status":"UNKNOWN","sponsor":"Javelin Pharmaceuticals","startDate":"2007-08","conditions":"Pharmacokinetics","enrollment":48},{"nctId":"NCT00488787","phase":"PHASE2","title":"Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain","status":"COMPLETED","sponsor":"Javelin Pharmaceuticals","startDate":"2001-03","conditions":"Pain, Postoperative","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CI-581-b","genericName":"CI-581-b","companyName":"New York State Psychiatric Institute","companyId":"new-york-state-psychiatric-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CI-581-b is a dissociative anesthetic that acts as an NMDA receptor antagonist to produce rapid-onset anesthesia and analgesia. Used for Anesthesia induction and maintenance, Procedural sedation and analgesia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}